[HTML][HTML] New developments in osteoarthritis and cartilage biology
B Poulet, KA Staines - Current opinion in pharmacology, 2016 - Elsevier
Highlights•Osteoarthritis (OA) is a common and debilitating disease with no effective
treatments.•Articular chondrocyte behavior and matrix maintenance are major targets.•The …
treatments.•Articular chondrocyte behavior and matrix maintenance are major targets.•The …
Emerging targets in osteoarthritis therapy
MB Goldring, F Berenbaum - Current opinion in pharmacology, 2015 - Elsevier
Highlights•Different OA etiologies present a challenge for developing a single targeted
therapy.•Common mechanisms occur in inflammatory, mechanical, and oxidative stress in …
therapy.•Common mechanisms occur in inflammatory, mechanical, and oxidative stress in …
From osteoarthritis treatments to future regenerative therapies for cartilage
Osteoarthritis (OA) is associated with cartilage degeneration and an accompanying
inflammatory syndrome of the synovium in addition to alteration of the subchondral bone …
inflammatory syndrome of the synovium in addition to alteration of the subchondral bone …
Therapeutics in osteoarthritis based on an understanding of its molecular pathogenesis
JR Kim, JJ Yoo, HA Kim - International journal of molecular sciences, 2018 - mdpi.com
Osteoarthritis (OA) is the most prevalent joint disease in older people and is characterized
by the progressive destruction of articular cartilage, synovial inflammation, changes in …
by the progressive destruction of articular cartilage, synovial inflammation, changes in …
Current advances in therapies for osteoarthritis
KC Kalunian - Current Opinion in Rheumatology, 2016 - journals.lww.com
Current advances in therapies for osteoarthritis : Current Opinion in Rheumatology Current
advances in therapies for osteoarthritis : Current Opinion in Rheumatology Log in or Register …
advances in therapies for osteoarthritis : Current Opinion in Rheumatology Log in or Register …
[HTML][HTML] OA clinical trials: current targets and trials for OA. Choosing molecular targets: what have we learned and where we are headed?
MPH Le Graverand-Gastineau - Osteoarthritis and cartilage, 2009 - Elsevier
OBJECTIVE: The purpose of this article is to review the current status of drug development
as it relates to both molecular targets and clinical trials for osteoarthritis (OA). METHODS: A …
as it relates to both molecular targets and clinical trials for osteoarthritis (OA). METHODS: A …
[HTML][HTML] An up to date on clinical prospects and management of osteoarthritis
The rising prevalence of osteoarthritis (OA) in the general population has necessitated the
development of novel treatment options. It is critical to recognize the joint as a separate …
development of novel treatment options. It is critical to recognize the joint as a separate …
[PDF][PDF] Future directions for research and treatment of osteoarthritis
CJ Malemud, VM Goldberg - Front Biosci, 1999 - article.imrpress.com
[Frontiers in Bioscience 4, d762-771, October 15, 1999] 762 FUTURE DIRECTIONS FOR
RESEARCH AND TREATMENT OF OSTEOARTHRITIS Charl Page 1 [Frontiers in Bioscience 4 …
RESEARCH AND TREATMENT OF OSTEOARTHRITIS Charl Page 1 [Frontiers in Bioscience 4 …
The future of osteoarthritis therapeutics: emerging biological therapy
A Mobasheri - Current rheumatology reports, 2013 - Springer
Biological therapy is a thriving area of research and development, and is well established for
chronic forms of rheumatoid arthritis (RA) and ankylosing spondylitis (AS). However, there is …
chronic forms of rheumatoid arthritis (RA) and ankylosing spondylitis (AS). However, there is …
Emerging pharmaceutical therapies for osteoarthritis
A Latourte, M Kloppenburg, P Richette - Nature Reviews Rheumatology, 2020 - nature.com
The prevalence of osteoarthritis (OA) and the burden associated with the disease are
steadily increasing worldwide, representing a major public health challenge for the coming …
steadily increasing worldwide, representing a major public health challenge for the coming …